Skip to main content
Skip to section navigation
Skip to footer
French
English
About Us
Management
Board of Directors
Scientific Advisory Board
Clinical Pipeline
GTX-104
GTX-102
GTX-101
Investor Relations
Overview
News / Events
Company Info
Financial Results
Stock Data
Regulatory Filings
Governance
Newsroom
Careers
Contact
French
Press Releases
Investor Relations
Investor Relations
Overview
News / Events
Overview
Press Releases
Media
IR Calendar
Email Alerts
Company Info
Overview
Presentations
Contacts
FAQ
Financial Results
Stock Data
NASDAQ: ACST
Analyst Coverage
Regulatory Filings
Overview
All SEC Filings
Annual Reports
Section 16 Filings
SEDAR
Tax Notifications
Governance
Management Team
Board of Directors
Board Committees
Governance Documents
Board Diversity Matrix
News / Events
Overview
Press Releases
Media
IR Calendar
Email Alerts
Year
All Years
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
Category
All Releases
Financial Releases
Acasti Signs Manufacturing Agreement
Jul 31, 2013
Acasti Announces First Quarter Results
Jul 15, 2013
Acasti Reports Results of Annual and Special Meeting
Jun 28, 2013
Acasti Announces Fiscal 2013 Results and Provides Update on Status of Clinical Trials
May 22, 2013
Acasti Pharma Presents Preliminary Data Moving Forward With Clinical Strategy
Mar 19, 2013
Acasti Pharma Reports Its Third Quarter Results
Jan 15, 2013
Acasti Pharma Shares to Trade on NASDAQ
Jan 7, 2013
Acasti Pharma Provides an Insight of Its Current Clinical Trials Results
Dec 17, 2012
Acasti Pharma Becomes Royalty Free
Dec 4, 2012
Acasti Pharma Provides Update After Explosion at Neptune's Plant
Nov 12, 2012
rss_feed
News RSS
Prev
1...
17
18
19
20
21
22
23
24
25
26
Next
Email Alerts
Tear Sheet
Contacts
RSS News Feed
back-to-top